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 Macrophages play a critical role in regeneration following peripheral nerve injury. 
Hematogenous macrophages are recruited to the distal nerve segment and shape the 
injured nerve microenvironment to be more conducive to regeneration through the 
clearance of cellular debris and the production of neurotrophic factors. Enhanced 
macrophage recruitment and debris clearance has been observed in BACE1 KO mice. 
This phenotype could be the result of BACE1 activity in macrophages, other nerve 
resident cells (neurons, Schwann cells), or it could also be the result of the 
hypomyelination phenotype that is also observed in BACE1 KO mice. To date it is 
uncertain what potential mechanisms may be driving this enhanced recruitment and 
debris clearance phenotype. Further, it is unknown which cell types in the peripheral 
microenvironment contribute most towards this phenotype when BACE1 is deleted. 
BACE1 is a promiscuous enzyme and has many substrates, thus may play a role in a 
variety pathways that could result in this enhanced macrophage recruitment and debris 
clearance phenotype. This thesis discusses several known BACE1 substrates and how 
they could impact macrophages in the context of peripheral nerve regeneration. Previous 
work done in our lab suggests that elimination of expression of BACE1 in cells derived 
from bone marrow may recapitulate the enhanced macrophage recruitment and activity 
phenotype. This thesis utilizes a mouse model with macrophage specific deletion of 
BACE1 to investigate whether BACE1 expression by macrophages mediates the 
immumodulatory phenotype observed in global BACE1 KO mice. This thesis 
demonstrates that there is not enhanced recruitment of macrophages to the injured 




expression by macrophages is not essential for the increased recruitment phenotype 
observed in global BACE1 KO mice. 
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Chapter 1: Introduction 
Introduction 
  The peripheral nervous system has limited capacity for regeneration in 
response to injury. However, this level of regeneration is still insufficient to restore full 
function and mitigate morbidity and disability in humans. Following peripheral nerve 
injury, extensive coordination of several different cell types is required for the degeneration 
and subsequent regeneration of the peripheral nerve, beginning with the breakdown of 
axons and myelin sheaths into amorphous debris. Next, in order to create a 
microenvironment conducive to axonal regeneration, macrophages are recruited from the 
circulation to the distal nerve segment to clear this cellular debris and promote axonal 
regeneration through the release of neurotrophic factors. While neurons and Schwann cells 
play a critical role in the regeneration process, the focus will be on the role of macrophages, 
how they interact with the other cells of the injured nerve microenvironment and how 
inhibition of BACE1 may play a role in modulating these interactions.   
Beta-Site Amyloid Precursor Protein (APP) Cleaving Enzyme 1, also known as β-
Secretase (BACE1) has been extensively studied for its role in Alzheimer’s disease. 
Cleavage of APP by BACE1 and subsequent cleavage by γ-secretase leads to the 
generation of Aβ peptides that form Aβ plaques that are a pathological hallmark of 
Alzheimer’s disease. In addition to this role in disease, BACE1 activity is involved in other 
biological processes. The genetic deletion or pharmacological inhibition of BACE1 results 
in increased recruitment of macrophages and subsequent cellular debris clearance in the 




little is known about the underlying mechanism of this enhanced recruitment and debris 
clearance. The major cell types that comprise the microenvironment of the injured 
peripheral nerve and could be mediating this phenotype are neurons, Schwann cells, and 
hematogenous infiltrating macrophages but the relative contributions of each remain 
unknown. In order to elucidate a potential mechanism, it would be most prudent to start 
with possible signaling pathways that contain currently known BACE1 substrates that have 
immunomodulatory capacity. The focus of this review will be the role of macrophages in 
peripheral nerve injury, how BACE1 modulates macrophage behavior, and discuss known 


















Fig 1. Sequence of events post-nerve injury 
A motor neuron (left) innervates muscle tissue (right) via axon myelinated by Schwann 
cells (center). After sustaining an injury, the distal nerve segment will degenerate into 
amorphous debris. Hematogenous macrophages (green) are recruited from circulation and 
enter the distal stump. Macrophages make the microenvironment more permissive for 
axonal regeneration by clearing cellular debris and releasing cytokines and neurotrophic 
factors. Axons regenerate with the guidance of Schwann cells and the aid of macrophages 
via neurotrophic factors and the elimination of debris which poses a physical barrier and 

















Degeneration following injury 
 Upon injury of a nerve there is initially a lag period before the segment of nerve 
distal to the site of injury begins to degenerate (2). The initial step of this process is a flux 
of extracellular Ca2+ to the inside of the axon (3). The depletion of extracellular calcium or 
blockage of Ca2+ ion channels can attenuate the degeneration of axons for up to 4 days (2). 
The effectiveness of channel blockage to delay degeneration illustrates that this process is 
related to the activity of calcium channels as opposed to Ca2+ flux that is the result of a 
compromised axonal membrane (2). Further, the proximal stump undergoes the same 
disruption during injury but this segment will not degenerate as the distal segment does (2). 
A consequence of this calcium flux is the activation of calpains, a family of proteases that 
are known to cleave cytoskeletal proteins such as neurofilament (2, 4–6).  
Great advancement into the mechanisms of Wallerian degeneration have emerged 
from the discovery of the C57BL/Wlds mouse, a spontaneous mouse mutant that exhibits 
very slow Wallerian degeneration (7). Wallerian degeneration refers to the breakdown and 
granular disintegration of the distal nerve stump following axonal injury (8, 9). Wlds is a 
fusion protein that has the enzymatic activity of nicotinamide mononucleotide 
adenylyltransferase (NMNAT) and a modified N-terminal sequence that results in the 
relocation of the protein to the cytoplasm of axons (10–12). NMNAT2 is actively 
transported from the cell body and catalyzes the formation of nicotinamide adenine 
dinucleotide (NAD+) from nicotinamide mononucleotide (NMN) (13, 14). Once an axon 
is severed this transport is blocked and due it it’s short half-life NMNAT2 rapidly degrades, 
resulting in decreasing NAD+ levels and rising NMN levels. This leads to axonal 




proposed that Wlds  is able to protect axons due to its axonal localization and increased 
stability compared to NMNAT2, allowing the continued synthesis of NAD+, delaying 
Wallerian degeneration (13, 16). Interestingly, there is evidence that degeneration can be 
promoted by the accumulation NMN as opposed to depletion of NAD+ as illustrated by 
the axonal protection when NMN-synthesizing enzyme inhibitors are used despite the 
downstream reduction in NAD+ (14). 
Further advancement came through the discovery that an equivalently robust 
blockage of Wallerian degeneration could be achieved through the deletion of Toll-like 
receptor adaptor protein Sterile alpha and TIR motif containing 1 (SARM1)(17). This 
provided evidence of a mechanism of Wallerian degeneration that was driven by normal 
biology rather than the result of a mutated fusion protein. SARM1 deletion can also rescue 
the axonal degeneration resulting from loss of NMNAT2 without reducing NMN (18), 
suggesting SARM1 plays a role in previously known pathways discovered in Wlds mice 
(19). SARM1 and NMN appear to be required for generating a flux of extracellular Ca2+ 
in response to injury, which could drive calcium dependent effectors suggested by (2). 
The process of axonal degeneration likely plays a role on the modulation of 
Schwann cells following injury through a potential injury signal or loss of axonal signaling 
(20). In response to injury Schwann cells will rapidly switch their transcriptional program, 
differentiate from a myelinating state to a repair state,  and  produce cytokines for the 







Recruitment of Macrophages to the site of Injury 
Monocyte differentiation and extravasation begins when inflammatory signals 
induce gene expression programs that allow increase expression of adhesion molecules to 
promote the binding of endothelial cells by monocytes to begin rolling and extravasation 
(25).  Correlating with the arrival of macrophages, the blood nerve barrier will become 
permeabilized to allow greater influx of hematogenous leukocytes into the distal nerve 
segment (26, 27). Macrophages begin to infiltrate into the distal segment after 3 days, peak 
around 6 days, and persist in large numbers for at least 14 days (28). 
To date several cytokines and chemokines have demonstrated a role in macrophage 
recruitment to the injured peripheral nerve, including Tumor Necrosis Factor α (TNFα), 
interleukin-1α (Il-1α), interleukin-1β (Il-1β), C-C motif chemokine ligand 2 (CCL2), 
leukemia inhibitory factor (LIF), and pancreatitis-associated protein III (PAP-III) (21–24, 
29–31). In experiments where these cytokines are disabled, macrophage recruitment is 
attenuated to varying degrees but the loss of any single molecule does not completely block 
recruitment (22). While the reduction of any cytokine or chemokine individually will not 
completely abrogate the recruitment of macrophages, it does illustrate that this is a robust 
response that is the result of mobilization through multiple pathways (21).  
In addition to chemoattractant proteins produced by constituent cells in the nerve 
for the purpose of recruitment of hematogenous leukocytes, there is also evidence of 
humoral components of the immune system taking part in recruitment. Complement is a 
humoral component of the innate immune system that is able to opsonize and begin a 
cascade of proteolytic cleavage of complement proteins to act as chemoattractants and 




signals in three ways. The cleavage cascade can start with the recognition of bound 
antibodies, recognition of mannose-binding lectins, and spontaneous binding and 
activation in the absence of inhibitory signals (32). In co-culture experiments with 
macrophages and degenerating nerves there is a reduction in the ability for macrophages 
to invade the nerve when complement is depleted (33). This reduced recruitment effect is 
also observed in vivo in mice that have been depleted of complement by cobra venom 
factor (34). There is also evidence that some of these receptors have functional overlap, 
playing a role in recruitment and  phagocytosis. In addition to complement, the scavenger 
receptor may also  play a role in the recruitment of macrophages as demonstrated when an 
anti-scavenger receptor antibody blocked recruitment of macrophages in a nerve explant 
co-culture experiment (35).  
Observations like these highlight the interconnectedness of the inflammatory 
response, the various pathways involved, and the versatile nature of macrophages in this 
process. Macrophages are critical to the process of regeneration because when recruitment 
is attenuated there is reduced myelin debris clearance, axonal regeneration and functional 
recovery (22, 36). 
 
Role of macrophages in cellular debris clearance 
 A critical component of peripheral nerve regeneration is the removal of myelin and 
axonal debris in the distal nerve segment. Not only is this debris a physical barrier to the 
regenerating nerve but the debris also contains inhibitory signaling molecules that further 
attenuate the regenerating axon (37–40). The bulk of this process takes within 20 days 




phases, initially driven by endogenous Schwann cells and resident macrophages in the first 
6 days and later by infiltrating hematogenous macrophages (28, 42–46).  
 Upon arrival into the distal nerve stump, macrophages begin phagocytosis of axonal 
and myelin debris. This process is, in part, driven by traditional opsonizing elements of the 
humoral immune system. In a study using a mouse model that lacks mature B-cells and 
thus cannot produce antibodies, saw attenuated clearance of myelin debris. This effect was 
rescued by serum or purified IgG/IgM from a donor mouse.  These antibody deficient mice 
were also observed to have less lysozyme expression and diminished phagocytic 
morphology (28). Complement has also been shown to be an important opsonin for 
macrophage phagocytosis in the peripheral nerve (33, 34). In the absence of complement 
component 3 (C3), a protein critical for complement activation, macrophages that have 
already invaded degenerating nerves in co-culture, display a significant reduction in 
phagocytosis of myelin debris (33).  
Beyond opsonin-dependent phagocytosis of myelin debris there is also evidence of 
the involvement of the versatile scavenger receptor in the mediation of phagocytosis (35, 
47). The scavenger receptor is functionally versatile as it plays a role phagocytosis through 
broad extracellular milieu ligand specificity and also plays a role in the recruitment of 
macrophages (35, 48). In a sciatic nerve explant and peritoneal macrophage co-culture 
experiment in which an anti-scavenger receptor antibody was used, there was a significant 
decrease in myelin phagocytosis. Morphological data also corroborated this effect as 
significantly less pseudopodia and post-phagocytic myelin was observed in these 
macrophages (35). It is not clear if any other opsonin-independent pathways are involved 




phagocytosis has been observed in Schwann cells so similar mechanisms may be relevant 
to macrophages (41).  
 
Neurotrophic functionality of Macrophages  
Macrophages can contribute neurotrophic signaling to the regenerating nerve in a 
variety of ways. Conditioned media produced by macrophages that have phagocytosed 
myelin debris can increase survival and neurite quantity of dorsal root ganglia neurons in 
culture (49). Schwann cells have a reduced capacity for phagocytosis when macrophages 
are depleted, this may be evidence that macrophages provide important signaling to 
Schwann cells in order to get them to ramp up their debris clearance mechanisms (41). 
Macrophages play a critical role in sensing the hypoxic environment cause by the 
disruption of blood vessels. Macrophages produce vascular endothelial growth factor 
(VEGF) in response to hypoxia, stimulating polarized angiogenesis of blood vessels that 
form a scaffold for Schwann cells to follow in order to reach the distal nerve segment 
following nerve transection (50). 
Another cohort of macrophages will persist in the distal nerve segment for at least 
6 weeks following injury and provide pro-regenerative signaling molecules to the 
regenerating axons and Schwann cells (50, 51). These persisting macrophages aid in  
regulating the return of Schwann cells to a myelinating differentiation state to myelinate 
regenerating axons. Ablation of macrophages after a week post injury led to increased 
Schwann cell proliferation, a reduction in myelinated axons, and reduced recovery of 
compound motor action potential (CMAP) but had no effect on CMAP amplitude or axonal 




mediator of this phenotype and found that in a bone marrow transplant experiment with 
Gas6 KO mice that there was altered remyelination, specifically in regard to internodal 
length (51).  
 Macrophages are involved in a heavily regulated remodeling process of the 
extracellular matrix (ECM). This process involves delicate balance of enzymes involved 
in digestion of ECM components, known as matrix metalloproteinases (MMPs), and their 
inhibitory counterparts (52). The degenerating nerve basement membrane must be 
permeable enough to allow the influx of hematogenous macrophages but must remain 
intact to provide benefits to the regenerating axon. The basement membrane  provides a 
niche in which the Schwann cells can proliferate and await the regenerating axon to 
remyelinate it (52, 53).  
Following injury, macrophages will not only recruit to the site of injury but they 
will also recruit and associate with injured neuronal cell bodies in dorsal root ganglia 
(DRG) (54). The DRG infiltrating macrophages will arrive after 48 hours and will persist 
for at least 28 days (54–56). In Ccr2 KO mice this infiltration is abolished which suggests 
that Ccl2 is critical for the recruitment of macrophages to DRGs containing cell bodies of 
injured axons (55). These macrophages seem to have neurotrophic effect, demonstrated 
when their recruitment to DRGs is blocked, there is attenuation the enhanced regenerative 
capacity of axons that had sustained a conditioning lesion in several models (56). A 
conditioning lesion will normally activate neuronal regeneration associated gene programs 
that will reduce the latency time for axonal regeneration if there is a second insult. 




macrophages which may suggest that these DRG interfacing macrophages exhibit a pro-
regeneration polarization state (55). 
 
Beta Secretase 
BACE1 is a well-studied enzyme in the field of Alzheimer’s disease. However, this 
enzyme’s promiscuous substrate specificity results in potential roles in multiple processes 
beyond the pathology of Alzheimer’s disease. This enzyme is a transmembrane aspartyl 
protease that is a critical participant in the cleavage of Amyloid Precursor Protein (APP) 
and generation of Aβ plaques, one of the pathological hallmarks of Alzheimer’s disease. 
Initially BACE1 will cleave APP on the luminal side of the cell membrane, releasing a 
large soluble ectodomain and leave behind the remaining truncated transmembrane and 
intracellular domains. This cleavage event is the rate limiting step in the generation of Aβ 
fragments. Subsequent cleavage by gamma secretase in the transmembrane domain will 
generate the Aβ fragment and APP intracellular domain (57). BACE1 substrates are mostly 
type 1 transmembrane proteins however, there are exceptions like St6gal, which is a type 
2 transmembrane protein (58). Its broad substrate specificity has led to the discovery of 
over 60 known substrates of BACE1. Thus far BACE1 has been found to have the highest 
expression in brain and the pancreas, although they have high and low enzymatic activity 
in each, respectively (59).  Expression is present in other peripheral tissues but only very 
low amounts. Genetic and pharmacological manipulation of BACE1 has revealed several 
phenotypes that are of particular interest to the process of peripheral nerve regeneration. 




of nerve regeneration, intrinsic neuronal regeneration capacity, inhibitory debris clearance, 
and pro-regeneration effects of Schwann cells. 
BACE1 KO neurons have a greater capacity for regeneration than their wild type 
counterparts. While BACE1 KO mice do not experience shortened latency before axonal 
regeneration begins, they do grow more rapidly once regeneration begins after 2 days. This 
latency can be shortened with a conditioning lesion in BACE1 KO mice but it does not 
improve upon the conditioning lesion response seen in WT mice. By day 3 following a 
crush injury, BACE1 KO axons grow significantly further distally than WT and this 
difference increases over longer time points. Not only do the axons grow more rapidly, but 
there is also a greater number of regenerating axons in the BACE1 KO. This improvement 
in regeneration results in greater reinnevation of neuromuscular junctions (NMJs) as early 
as 10 days post injury (1). BACE1 also plays a role in the regulation of Schwann cells. In 
BACE1 KO mice, peripheral nerves are hypomyelinated which is likely due to 
dysregulation of neuregulin 1 type III, a known BACE1 substrate that plays a role in the 
myelination of axons (60, 61). While reduced BACE1 activity has a pro-regenerative 
effect, the opposite is true of BACE1 overexpression.  Overexpression of human BACE1 
in neurons of transgenic mice results in decreased axonal regeneration, reduced NMJ 
reinnervation, and impaired functional recovery following crush injury (62). There was no 
effect on myelination observed when BACE1 is overexpressed in neurons (62).  
In BACE1 KO mice there is an increase in macrophages that are recruited to the 
distal nerve segment following nerve injury. While these macrophages do not appear to 
arrive any earlier than expected, they do so in greater populations. In vivo morphological 




by an increase in the number of macrophages with a myelin-laden foamy appearance. This 
increased phagocytosis is also observed in vitro when primary mouse intraperitoneal 
macrophages are exposed to mouse gamma globulin opsonized polystyrene beads. This 
increased in vitro phagocytosis may lead to increased axonal debris clearance in vivo, 
observed as diminished YFP fluorescence following nerve injury in a mouse line that 
expresses YFP in a subset of axons  (1). It is unclear if these macrophages are able to clear 
cellular debris more efficiently than WT counterparts because BACE1 KO mouse axons 
are hypomyelinated, making direct comparison more challenging (63, 64). The improved 
clearance of axonal debris may be the result of the hypomyelination phenotype leading to 
less debris to be cleared by macrophages overall. At this time it is unclear of whether 
BACE1 activity modulates macrophages directly or indirectly.  
In order to begin to determine the mechanisms of this phenotype, a critical step is 
to determine what the consequences are of reduced BACE1 activity in the various cell types 
of the regenerating nerve microenvironment. A nerve grafting experiment was done where 
BACE1 KO or WT sciatic nerves were grafted into a recipient sciatic nerve, essentially 
flanking the donor graft both proximally and distally with host nerve tissue. Interestingly 
there was increased axonal growth when WT graft was placed into BACE1 KO host but 
not vice versa (1). This suggests that the BACE1 activity status of the recipient is more 
important than that of the donor. The likely cell types mediating this recipient effect are 
the neurons and/or macrophages. Neuronal cell bodies are located proximal to the graft 
tissue and macrophages are recruited from recipient circulation. The graft tissue illustrates 
the role of BACE1 activity on Schwann cells in this phenotype. This experiment suggests 




permissive environment for regeneration (1). After 7 days post sciatic nerve transection 
Tumor Necrosis Factor Receptor 1 (TNFR1) expression was nearly doubled in sciatic 
nerves of BACE1 KO mice. This increased expression was also observed in mice that 
received BACE1 KO donor marrow in a bone marrow transplant experiment. At this time 
it is unclear whether this is an upregulation of TNFR1, the result of increased macrophage 
recruitment, or a combination of both due to the loss of BACE1 activity (65). 
 
BACE1 Substrates with immunomodulatory potential 
Interleukin 1 receptor 2 (Il1-R2)  
Interleukin 1 is a potent and highly regulated pro-inflammatory cytokine. It exists 
as a family of ligands with agonist activity and receptor antagonists that bind to a family 
of receptors and accessory proteins as reviewd by (66). For the purposes of this review the 
focus will be on IL-1α and IL-1β ligands and their receptors. Both ligands are synthesized 
as pro-cytokines and must be cleaved in order to become more active and bind the 
Interleukin-1 receptor. However, the way each ligand is activated through cleavage and 
released from cells is markedly different (67). Il-1α and Il-1β both bind Il1-R1 which 
provides route of common regulation between the two ligands. Regulation of Il1-R1 occurs 
through the decoy receptor, Interleukin 1 receptor 2 (Il-1R2), and soluble receptor 
antagonist, Interleukin 1 receptor antagonist (Il-1RA). Despite the commonality of their 
regulatory components evidence suggests that Il-1α and Il-1β have different activities and 
effects (67, 68).  
Il-1α is a dual function cytokine with functionality in both its pro-form as a 




has intracellular activity as a transcriptional regulator in addition to being released from 
necrotic cells to act as a damage associated molecular pattern (DAMP) to cells bearing the 
Il-1 receptor (Il-1R1) and Interleukin-1 receptor accessory protein (Il-1RAcP) (67, 70, 71). 
However, Il-1α is sequestered in nuclear foci under apoptotic conditions instead of being 
released into the milieu where it can induce an inflammatory response. When apoptotic 
cells are placed in matrigel, there is no recruitment of myeloid cells. In contrast, where 
robust infiltration of myeloid cells is observed when necrotic cells were embedded in 
matrigel (68, 69). Il-1α can induce sterile inflammation while in the pro-form but its 
potency is increased by proteolytic processing. Its affinity for Il-1R1 can be increased by 
proteolytic cleavage into its mature form by leukocyte derived enzymes in the extracellular 
milieu such as granzyme B, chymase and neutrophil elastase (72, 73). If there is sufficient 
Ca2+ flux in a cell as a result of signaling processes or cell membrane damage, Il-1α can be 
cleaved by intracellular calpain into its active form (67, 74, 75).  Mature Il-1α can induce 
a range of responses in different cells types including leukocyte recruitment, maturation, 
differentiation, proliferation, and inflammasome priming (66). 
Unlike Il-1α, Il-1β is not constitutively expressed and requires a priming signal for 
the cell to begin producing it to further the inflammatory response. Pro-Il-1β is expressed 
in macrophages in response to a priming signal in the form of Il-1α and other NF-κβ 
activating pathways, such as TLRs or TNFR (76, 77). Once the cell receives a second 
activating signal, pro-Il-1β is cleaved into its active form by either Caspase-1 or Caspase-
8. Caspase-1 dependent pro-Il-1β cleavage is the result of a signal that triggers the assembly 
of the inflammasome, which cleaves pro-Caspase-1 into its active form that results in 




 Il-1R2 is a decoy receptor for both Il-1α and Il-1β that can negatively regulate Il-1 
signaling in both cells expressing this decoy receptor and cells exposed to the secreted (sIl-
1R2) or shed shIl-1R2) forms of the receptor. When located on the plasma membrane Il1-
R2 will complex with Il-1RAcP and act as a non-signaling binding partner for Il-1 at the 
cell surface. This relationship with Il-1RAcP also allows Il-1R2 to act as a sink for the 
necessary accessory protein for Il-1R1 and further negatively regulate Il-1 signaling (79, 
80). A cytosolic form of Il-1R2 (icIl1-R2) can also bind Il-1α intracellularly and prevent 
maturation of Il-1α (81). In addition to these forms of Il-1 cis-regulation, there is also trans-
regulation mediated by the shed and secreted soluble forms, that can bind Il-1 before it can 
bind Il-1R1. Il-1R2 is primarily expressed on leukocytes but can be induced on other cell 
types such as keratinocytes and endothelial cells (80, 82, 83). 
Although Il-1 is a heavily regulated signaling pathway, cells have ways to get 
around Il-R2 in certain circumstances. The soluble form of Il-1R2 can be cleaved by 
caspase-1 after activation of the inflammasome (81). This cleavage by caspase-1 attenuates 
the ability of icIl-1R2 to bind Il-1α, which can restore its ability to act as a DAMP. 
Membrane bound Il-1R2 can be cleaved into shIl-1R2 by different “sheddases” such as 
ADAM17 or BACE1 (58, 84, 85). This makes sheddases very important components to 
this regulatory system as they not only serve to restore cell membrane Il-1R/Il-1RAcP 
function, but also may be important for generating shIl-1R2 which can bind extracellular 
Il-1α and Il-β attenuate signaling. This opens the possibility of a context dependent 
pleotropic role for sheddases, like BACE1, in the regulation of the Il-1 signaling pathway 
could have implications for the immunomodulatory phenotype observed in the injured 




In the context of sterile inflammation both Il-1 ligands play significant roles. Il-1α 
is most influential as a DAMP at the initiation of inflammation. Il-1β is more important in 
its role of macrophage recruitment and phagocytic activity (22). Further, in the context of 
hypoxic sterile inflammation Il-1α is released from dying cells, recruits neutrophils to the 
site, and Il-1β recruits and retains macrophages (68). Similarly, following nerve injury the 
blood vessels are disrupted and cells are capable of sensing the hypoxic environment and 
altering their expression profile accordingly (50). The nature of macrophages in peripheral 
nerve regeneration appears to be pleotrophic, perhaps reflecting the waves of cytokines and 
cell types associated with injury. An acute highly regulated inflammatory response 
followed by a shift to an anti-inflammatory pro-regenerative phenotype (86).  
Il-1 plays an important role in peripheral nerve regeneration. Following an injury 
of the peripheral nerve there is rapid and robust induction of IL-1β expression in a small 
population of cells near the site of injury (22). This change occurs after one hour which is 
nearly 12 hours prior to arrival of neutrophils and later hematogenous macrophages. Given 
the timing of this expression change it is unlikely to be hematogenous leukocytes, although 
there is a second peak of Il-1β expression at 14 days that is likely due to influx of 
hematogenous macrophages (22). It is possible that these Il-1β generating cells could be a 
subset of Schwann cells or fibroblasts, however, macrophages are known to express Il-1β 
in response to inflammatory stimuli such as Il-1α or other endogenous molecules released 
into extracellular space. Resident macrophages account for approximately 10% of all 
nucleated cells in uninjured nerves (45, 87, 88) so the sparsity of cells that are heavily 
expressing Il-1β would make these cells a likely source, although expression of Il-1β has 




in the nerve so it would be present to serve as a DAMP to prime Il-1β expression following 
injury. Mature Il-1β levels begin to increase after 6 hours, a two fold increase, which 
increases further to 10 fold by 24 hours (23, 89). This maturation mirrors the processing of 
pro-caspase, which suggests that this is mediated by activation of the inflammasome. Mice 
that have defects of Il-1 signaling have impaired functional recovery compared to WT, 
which suggests that there is benefit to this inflammatory signaling (23). On the other hand, 
Il-1β also plays a role in neuropathic pain as the result of inflammation. Il-1β/TNFα double 
knockout mice have reduced mechanical allodynia but also display evidence of impaired 
functional recovery (23). However, depletion of neutrophils, as opposed to blockage of 
cytokine signaling, improved neuropathic pain thresholds and restored functional recovery 
to WT levels (23).  
 Il-1R2 has been extensively studied in the context of the immune system and 
inflammation. BACE1 cleavage of IL1-R2 could influence many parts of this signaling 
pathway. BACE1 activity could boost the trans regulatory effect of Il1-R2 on adjacent cells 
through shedding of Il1-R2 into the extracellular milieu. The opposite could be true of its 
cis regulatory activity. Reduced BACE1 expression could lead to more Il-R2 remaining on 
the cell surface to block that cell’s ability to respond to Il-1 and sinking Il-1RAcP.  It is not 
fully understood how icIL1-R2 is generated so perhaps BACE1 may play a role, given its 
ability to generate shIL1-R2. Increased levels of icIL-1R2 could interfere with the calpain 
mediated maturation of Il-1α. This would reduce the ability of cells experiencing calcium 
flux to be able to use Il-1α to act as a DAMP and have downstream consequences for the 
inflammatory process as a whole. Decreasing BACE1 expression could reduce the amount 




pathway is heavily regulated and has many redundancies that would limit the ability of 
BACE1 to have a dramatic impact on any single regulatory site, but perhaps it can influence 
the pathway in several different regulatory sites and drive the overall response in a pro-
regenerative direction by leveraging the benefits of the inflammatory response, while 
minimizing its detrimental effects.  
Optimal regeneration seems to be heavily reliant on very tight regulation of the 
inflammatory response following injury. If there is not enough of an inflammatory response 
then there is attenuated immune cell recruitment for trophic signaling and debris clearance. 
However, if the inflammation response is too great then there can be deleterious effects of 
this such as the development of neuropathic pain (23). Any alterations of the immune 
response for therapies will require a breadth of knowledge of how the various cell types 
and pathways are interconnected and influence one another to maximize the balance of 







Fig 2. Possible regulatory mechanisms of IL-1 by BACE1 activity  
Il1-R2 regulation of Il-1 signaling. (1) Il-1α or Il-1β binds Il1-R1 and Il-RAcP resulting in 
normal signaling. (2) Il1-R2 binds Il-1RAcp and either Il-1α or Il-1β but does not result in 
signaling. (3) Il1-R2 can regulate Il-1 signaling by binding Il-1RAcP and which leaves it 
unable to complex with Il-1R1 for signaling. (4) Il1-R2 can be secreted or shed by cells 
and can bind Il-1α and Il-1β extracellularly and prevent them from binding Il1-R1/Il-
1RAcP. (5) BACE1 is one of a few enzymes capable of cleaving Il-1R2. BACE1 activity 
could influence the relative amounts of Il-R2 present in the cell membrane or shed into 
extracellular space. (6) Intracellular Il-1R2 can bind either pro-Il-1α and pro-Il-1β and 






 Notch is a transmembrane protein that can be activated through ligand binding of 
an adjacent cell. This binding results in a conformational change in Notch that makes it 
more vulnerable to a series of proteolytic cleavages that release the Notch intracellular 
domain (NICD) into the cytoplasm where it subsequently relocates to the nucleus and 
activates target genes for transcription with the help of other coactivating proteins (90). 
This pathway does not have a mechanism for amplification so the strength of the signal is 
the result of the abundance of Notch receptors on the receiving cell and the amount of 
ligand on the sending cell. The ratio of Notch to ligand can also be an important part of the 
pathway’s regulation. Cis inhibition of Notch occurs when a cell is expressing sufficient 
amounts of the ligand on its surface and that ligand binds to Notch instead the ligand from 
an adjacent cell (90, 91). As a result of cis inhibition the sending/receiving state of the cell 
can be largely determined by this receptor to ligand ratio. For example if the amount of 
Notch receptor is greater than the amount of ligand then that cell is likely to be a receiver, 
the opposite is true of cells with more ligand.  Ligand binding efficiency can also provide 
another layer of regulation to the Notch pathway (92). Jag1 has a relatively low binding 
affinity Notch, yet can render a cell unresponsive to other Notch ligands with greater 
binding affinity, adding an additional layer of complexity to this pathway (93).  
 BACE1 has also been shown to have a role in regulation of the Notch signaling 
pathway via cleavage and shedding of Jag1 (94). In BACE1 KO mice there is an abundance 
of full length Jag1 in the hippocampus. This abundant Jag1 ligand results in more activated 
Notch that is detected via increased NCID in this region of the brain. In vitro 




effect is reversed when cells are treated with a BACE inhibitor. BACE1 demonstrates 
specificity for Jag1 as it is unable to efficiently cleave its homolog Jag2. These studies 
suggest that BACE1 is a regulator of Notch signaling via cleavage of its substrate Jag1 (94, 
95). The increased Jag1 in BACE1 KO mice causes a shift in the balance of notch and 
ligand resulting in a shift towards astrogenesis and away from neurogenesis in the 
developing brain. There is also evidence of BACE1 regulation of Notch signaling playing 
a role in the peripheral nerve. As mentioned previously, BACE1 KO mice have 
hypomyelinated axons  due to the loss of BACE1 dependent neuregulin 1 signaling. Notch 
has been shown to enhance the sensitivity of Schwann cells to NRG-1 (96).  In addition 
Schwann cells show increased proliferation in BACE1 KO mice (97) which suggests that 
it could be the result of increased Notch signaling due to the loss of BACE1 regulation of 
Jag1. BACE1 KO mice have increased full length Jag1 and Delta1 and downstream NICD 
in sciatic nerves compared to WT. The addition of another Notch ligand, Delta1, as a 
possible BACE1 substrate adds to the impact that BACE1 can have on the Notch pathway 
(97).  
 In addition to development and cell fate decisions, Notch signaling plays a role in 
the activity of macrophages (98–101). Macrophages typically express the Notch receptor 
relying on cells they interface with to provide ligand stimulation. Inflammatory cytokines 
and several TLR agonists have been shown to increase the expression of Notch in 
macrophages (98). In the context of wound healing the expression of Notch by infiltrating 
macrophages is dynamic and can increase 5 fold 3 days after sustaining a skin wound (99). 
This increase in Notch expression is accompanied by an increase in inflammatory markers 




Diabetic mice exhibit poor wound healing in the later stages and have sustained high 
expression of inflammatory markers. Reducing Notch signaling in these diabetic mice 
improves their late wound healing, suggesting that inflammatory response is important 
early in the healing process but can be deleterious if it persists (99). This paradigm is 
similar between wound healing and nerve regeneration. Both are marked by an early 
inflammatory phase where debris is cleared and more inflammatory cells are recruited, 
followed by a later phase characterized by growth factor release and the resolution of 
inflammation.  
 Notch signaling plays a role in modulating the inflammatory response of 
macrophages in a variety of ways. Notch signaling has been shown to increase the 
translocation of NFκβ to the nucleus where it can interact with NICD to boost its ability to 
act a transcriptional cofactor and boost the inflammatory response (98).  Cells that are 
transfected with NICD show increased NFκβ activation, particularly when in conjunction 
of an inflammatory stimulus such as LPS, which is an agonist of TLR4 which is one of the 
receptors upstream in the pathway. In an in vitro Notch activation assay, extracellular 
domains of Notch ligands Delta4, Jag1, and Delta1 were adhered to culture plates and 
macrophages were then introduced. These Notch ligands were shown to increase the 
expression of a downstream reporter gene in these macrophages. In another experiment 
macrophages that were transfected with a robust repressor of NFκβ signaling, SR-Iκβα, 
were unable to activate the pathway, even in the presence of NCID. This suggest that Notch 
signaling is not activating a parallel pathway but impacting NFκβ and facilitating crosstalk 
between the two pathways (98). Notch also influences the phagocytic activity of 




dendritic cells, and some neurons and binds CD47 to block phagocytosis. This serves as a 
“don’t eat me” signal from host cells. The reduction of SIRPα results in loss of this signal 
and increases the phagocytic activity of macrophages. SIRPα activity also can attenuate 
the ability of macrophages to respond to inflammatory stimuli involved in polarization of 
macrophages toward an inflammatory phenotype. This suggests that SIRPα activity is not 
only important for phagocytosis but also in more broad mediation of the inflammatory 
response (100).   
 Given the abundance of Notch receptors and Notch ligands, it is unlikely that 
BACE1 would be able to have absolute regulatory control of any of these effects, but rather 
it could be a crucial mediator that helps tip the balance of signaling in the direction towards 
















Fig 3. Possible regulatory mechanisms of Notch signaling by BACE1 cleavage of Jag1  
Jagged-1/Notch signaling and regulation in the context of BACE1 activity. A cell that is 
sending (Top) a Notch signal to a receiving cell (Bottom) via notch ligand Jag1. (1) 
Notch/Jag1 binding causes a conformational change in Notch1 which results in subsequent 
cleavages resulting in the release of the intracellular domain of Notch (NCID) to relocate 
to the nucleus and activate downstream signaling. (2) Notch signaling can be regulated by 
binding Jag1 on the surface of the receiving cell. (3) BACE1 can regulate Notch1 signaling 
via the cleavage of Jag1. This cleavage can have different effects depending on whether it 
is taking place on a receiving cell or sending cell. In the sending cell, BACE1 activity 
results in reduced Jag1 available for signaling. In the receiving cell BACE1 activity results 












ST6 Beta-Galactoside Alpha-2,6-Sialyltransferase 1 (ST6Gal-1) 
ST6gal-1 is a sialyltransferase enzyme that plays a role in the post translational 
modification of proteins and modification of glycolipids by catalyzing α2,6 sialylation of 
N-glycans (102–104). While this enzyme is expressed in detectable amounts in nearly 
every tissue at a basal level, liver cells can rapidly upregulate expression of ST6gal-1 
during the inflammatory acute phase response (102). In addition to the increased expression 
driven by the inflammatory response there is also a proteolytic cleavage and release of 
ST6gal-1 into the serum (102). While this cleavage is likely a form of regulation, there is 
also evidence that certain cleaved forms of ST6gal-1 retain enzymatic activity. In a study 
of the sialylation of IgG in B cells (105) showed that when B cell ST6gal-1 was selectively 
ablated, there was still ST6gal-1 dependent sialylation of IgG in serum. (103) characterized 
an E41 cleaved form of secreted ST6gal-1 that was able to bind to an affinity column used 
to purify sialyltransferases, suggesting that this form retains its activity.  
BACE1 has been shown to cleave ST6gal-1 in vitro and in a study of BACE1 KO 
mice there was a decrease in serum ST6gal-1 compared to WT. The opposite effect was 
observed in mice that overexpress human BACE1, which showed an increase in serum 
ST6gal-1 (103). BACE1 expression and serum ST6gal-1 levels were also shown to be 
increased in a rat model of hepatitis, supporting earlier studies regarding hepatic 
inflammation playing a role (102). BACE1 cleavage of ST6gal-1 results in the generation 
of an enzymatically active form of ST6gal-1, E41 (103). 
BACE1 appears to play a role in the regulation of sialylation through its cleavage 
of ST6gal-1. This can have a range of immunomodulatory outcomes relevant to the 




literature suggests that in the context of ST6gal-1, BACE1 activity is beneficial for 
monocyte recruitment through enhancing macrophage/endothelial cell adhesion and by 
promoting extravasation by increasing endothelial cell-cell adhesion (25, 106). In a study 
of the monocyte cell line, U937, cells showed increased binding of VCAM-1 coated plates 
in a monocyte α4β1 integrin dependent manner following PMA mediated differentiation. 
This binding interaction of α4β1 on monocytes to endothelial VCAM-1 is important for 
the trafficking of monocytes to tissues following an inflammatory response. Sialylation of 
β1 integrins has been shown to be key regulator of the adhesion reaction between these 
adhesion molecules and VCAM-1 and fibronectin. Hyposialylated α4β1 shows increased 
binding affinity for VCAM-1. Upon differentiation of monocytes by PMA there is an 
increased expression of BACE1 associated with macrophage activation via protein kinase 
C (PKC) pathway. This increased expression of BACE1 leads to increased cleavage of 
ST6gal-1 and hyposialylation of α4β1. This hyposialylation and subsequent increased 
binding affinity correlates temporally with the activation of PKC and can be reversed when 
cells are treated with a BACE inhibitor (25). A different study by (106) highlighted the 
connection between the inflammatory response, BACE1 expression, and the modulation of 
cell adhesion. Treating a human monocyte cell line, THP-1 cells, with exogenous TNFα 
resulted in increased cell adhesion with endothelial cells in co-culture experiments. TNFα 
also caused a reduction in tight junction stability that was observed morphologically via 
electron microscopy in addition to reduced immunofluorescent VE-Cadherin staining. 
BACE1 expression increased in response to TNFα which in turn cause a global reduction 




in sialylation compromised endothelial cell-cell adhesion and enhanced monocyte 
adhesion to endothelial cells (106).   
 Evidence for BACE1 expression being upregulated by the inflammatory response 
is building as both of these experiments suggest this to be the case. While macrophage 
trafficking seems to be enhanced by BACE1 cleavage and downregulation ST6gal-1, 





















Fig 4. Possible mechanisms of BACE1 regulation of ST6gal-1 and PSGL-1  
Potential implications of BACE1 cleavage of ST6gal-1 and PSGL-1 on macrophage 
recruitment. The binding cascade leading to transendothelial migration and recruitment of 
leukocytes, in this case monocytes, begins with binding interactions between PSGL-1 and 
P-selection. These adhesion molecules disrupt flow of monocytes through the blood stream 
(1) by initiating the rolling and tethering to endothelial cells (2). This binding progresses 
until the arrest of the monocyte (3) with the addition of VCAM-1 and Integrin binding. At 
this point VCAM-1/Integrin binding takes over and plays a critical role through 
transendothelial migration (4). BACE1 cleaves ST6gal-1 resulting in decreased sialyation 
of α4β1 integrin, which increases it’s binding affinity to VCAM-1. Further, this 
hyposialyation leads to decreased endothelial cell-cell adhesion. This combination of these 
effects would like provide conditions more permissive to macrophage recruitment. 
Conversely, BACE1 cleavage of PSGL-1 would reduce the amount PSGL-1 available on 
the cell surface to bind with P-selectin. This would likely reduce the frequency of the initial 



























P-Selectin Glycoprotein Ligand-1 (PSGL-1) 
 P-selectin is constitutively expressed by endothelial cells and leukocytes, including 
monocytes, express PSGL-1. Transient binding interactions between p-selectin and its 
ligand PSGL-1 are critical for the initial rolling and tethering of monocytes to endothelial 
cells during recruitment to the injured nerve (107). While these binding interactions are 
short in duration, they result in the reduced velocities of leukocytes in the blood stream. 
This reduced velocity facilitates increased opportunity for increasing interactions between 
leukocytes and endothelial cells and chemokine signaling. During the rolling phase there 
is increasing integrin binding between endothelial cells and monocytes, which 
progressively slows the monocyte leads to arrest and extravasation. This cascade of 
adhesion and signaling interactions results in the activation, maturation, and trafficking of 
macrophages (107).  
 P-selectin has been shown to play a role in the recruitment of neutrophils and 
macrophages to the distal segments of nerves that had sustained partial sciatic nerve 
ligation (108). P-selectin KO mice had diminished recruitment to the injury site and a 
reduction of inflammatory cytokines TNFα, IL-1β, and IL-6 (108). This could be the result 
of downstream effects of inflammatory cytokines produced by cells populating the injury 
site, as it has been shown that IL-1 signaling results in increased expression of P-selectin 
by endothelial cells in mice. However, this effect has not been observed in humans. 
 BACE1 has been shown to cleave PSGL-1 in cell lines expressing endogenous or 
transfected BACE1 and no cleavage was observed in primary cells derived from BACE1 




result of reduced cleavage of PSGL-1 on the surfaces of endothelial cells and monocytes, 
increasing the number of binding interactions to begin rolling and tethering.    
 
Concluding remarks of the introduction 
 Regeneration following peripheral nerve injury is slow but given the critical role 
macrophages play in regeneration, immunomodulation of these cells may present an 
opportunity improve recovery and reduce morbidity associated with nerve injury. The 
substrate promiscuity of BACE1 could promote robust immunomodulation by acting on 
many pathways to alter the interactions of the various cell types in the peripheral nerve 
microenvironment. Further study is necessary to determine the relative contributions of 
each cell type in the peripheral nerve microenvironment for mediating the enhanced 









Chapter 2: Macrophage-specific deletion of BACE1 does not 
enhance macrophage recruitment to the injured peripheral 
nerve 
 
Introduction to chapter 2 
The following was published in J.A. Fissel and M.H. Farah, Macrophage-specific 
deletion of BACE1 does not enhance macrophage recruitment to the injured peripheral 
nerve. J.  Neuroimmunol 349, 577423 (2020). 
 
Following peripheral nerve injury, an orchestration of several different cell types 
contributes to the regeneration of the peripheral nerve. Initially, axons in the distal nerve 
segment degrade into amorphous debris (110). Next, myelin begins to break down and 
Schwann cells undergo a rapid transcriptional overhaul, modify their differentiation from 
a myelinating state to a repair state (111–113), and begin to release cytokines and 
chemokines to mobilize cells of the immune system for regeneration (21, 22, 23, 24, 31). 
Hematogenous macrophages are recruited to the distal nerve segment by cytokine and 
chemokine signaling to clear cellular debris (21–24, 29–31). This clearance is critical to 
remove a physical barrier to regenerating axons (114) and to eliminate the inhibitory 
effects of this debris (37–40). In addition to debris clearance, macrophages produce 
neurotrophic factors that further contribute to shaping a microenvironment conducive to 





Increased recruitment of macrophages and subsequent cellular debris clearance 
has been observed in the injured nerves of mice with genetic deletion or pharmacological 
inhibition of β-secretase (BACE1) (1). Currently, little is known about the underlying 
cellular mechanism of this enhanced recruitment and debris clearance. Neurons, Schwann 
cells, fibroblasts, and hematogenous infiltrating macrophages are the major cell types that 
comprise the microenvironment of the injured peripheral nerve and could be mediating 
this phenotype, but the role BACE1 expression plays in each cell type is unknown. 
Assessing the role of macrophages in the global BACE1 knockout (KO) mouse model 
has presented challenges due to the hypomyelination phenotype in these mice (1, 63, 64). 
This reduced myelination not only obfuscates analysis of myelin debris clearance in vivo, 
but also presents an alternative explanation that the enhanced recruitment and debris 
clearance observed in global BACE1 KO macrophages could be attributed to less myelin 
debris at baseline. Given that the hypomyelination phenotype is the result of signaling 
between axons and Schwann cells (60, 61), macrophage-specific deletion of BACE1 is 
unlikely to result in hypomyelination and presents the opportunity to assess the relative 
contribution of macrophages towards the enhanced recruitment and debris clearance 
observed in global BACE1 KO mice. Here, we crossed a floxed Bace1 mouse and a 
mouse possessing Cre recombinase under control of Lyz2 promoter/enhancer elements to 
obtain a conditional knockout (cKO) mouse with a macrophage-specific deletion of 
Bace1 in order to investigate the potential role of macrophage-derived BACE1 in 






The following was published in J.A. Fissel and M.H. Farah, Macrophage-specific 
deletion of BACE1 does not enhance macrophage recruitment to the injured peripheral 
nerve. J Neuroimmunol 349, 577423 (2020). 
 
BACE1 expression and activity is relatively low outside of the nervous system 
(115–117). However, considering previously published observations of improved 
recruitment and debris clearance by macrophages in injured peripheral nerves of global 
BACE1 KO mice, we sought to determine if BACE1 expression by macrophages 
increases in inflammatory contexts. To that end, we measured BACE1 expression in 
thioglycollate-activated murine peritoneal macrophages and observed an approximately 
ten-fold increase of BACE1 expression in macrophages that were activated by 
thioglycollate compared to non-thioglycollate treated controls (p = 0.0225) (Figure 1A). 
Considering that BACE1 expression increases in activated macrophages, we moved to 
assess potential effects of macrophage-specific deletion of BACE1 on macrophage 
recruitment following peripheral nerve injury. 
 
In order to ascertain the relative contribution of BACE1 expression by 
macrophages on enhanced macrophage recruitment and debris clearance phenotype, we 
sought to determine if macrophage-specific deletion of BACE1 is sufficient to 
recapitulate the modulation of macrophages observed in global BACE1 KO mice. The 
initial step in the characterization of cKO mice was to determine if there was successful 




macrophages harvested from macrophage-specific BACE1 cKO mice. Using RT-PCR we 
measured the expression of BACE1 in peritoneal macrophages from both cKO and 
heterozygous Cre expressing control mice and observed a significant reduction of 
approximately 80% in the cKO macrophages (p = 0.0010) (Figure 1B). We further 
characterized the nerves of cKO mice to determine if normal myelination of axons 
occurs. Given that the hypomyelination phenotype observed in global BACE1 is the 
result of signaling between axons and Schwann cells, we anticipated normal levels of 
myelination, and as expected, there was no difference in myelination between our cKO 
mice and Cre expressing controls as assessed by myelin thickness (p = 0.1962), 















Fig. 5. BACE1 expression in peritoneal macrophages increases under inflammatory 
conditions, is significantly reduced in Bace1fl/fl Lyz2 Cre +/WT macrophages, and has no effect 
on myelination in cKO mice. 
Peritoneal macrophages that are activated with thioglycollate have significantly higher 
expression of BACE1 mRNA compared to peritoneal macrophages that were not treated 
with thioglycollate (A). BACE1 mRNA expression is significantly reduced in peritoneal 
macrophages harvested from Bace1fl/fl;Lyz2 Cre +/WT mice relative to Lyz2 Cre +/WT 
control mice (B). N = 3 independent experiments with 3 mice for each 
condition/genotype, *p = 0.0225 (A), ***p = 0.0010 (B). Cross sections of uninjured 
sciatic nerves of Lyz2 Cre+/WT (C) and Bace1fl/fl;Lyz2 Cre +/- (D) have comparable levels 
of myelinated axons. There is no significant difference in myelin thickness, p = 0.1962, 
(E), myelinated axon density, p = 0.8970, (F), or g-ratio, p = 0.2985, (G), (n=3). Scale bar 
= 20µm for (C) and (D). J.A. Fissel and M.H. Farah, Macrophage-specific deletion of 
BACE1 does not enhance macrophage recruitment to the injured peripheral nerve. J  









After validation of macrophage-specific deletion of BACE1 in peritoneal 
macrophages, we proceeded on to assess the impact of BACE1 deletion on macrophage 
recruitment following peripheral nerve injury in vivo. Initial in vivo assessments were to 
determine if these mice have the same enhanced recruitment to distal nerve segments 
following sciatic nerve transection as observed in previous studies (1, 65). We measured 
recruitment in these mice by harvesting distal nerve segments and staining for CD68, a 
marker of macrophages, at 3 time points throughout the period of macrophage infiltration 
to the injured peripheral nerve. This dynamic period for recruitment begins at around day 
3, peaks near day 7, and then persists through day 14 (28). At day 3 post-transection we 
observed no visible difference in the number of macrophages at an early stage of 
recruitment to the injured nerve (Figure 2A,B). Upon quantification of the density of 
macrophages in the distal nerve segments, we confirmed there was no significant 
difference in between the genotypes (p=0.2557) (Figure 2C). Next, at day 5 post-sciatic 
nerve transection we observed no difference in recruitment of macrophages to the distal 
nerve segment (p = 0.8511) (Figure 2D-F). Finally, we measured the number of 
macrophages at day 7 to see if there was increased recruitment near the peak of the 
response, but again there was no difference (p=0.5371) (Figure 2G-I). Additionally, we 
considered that there may be an immunomodulatory effect driven by the Cre recombinase 
itself that could be masking the recruitment phenotype in these cKO mice (118), therefore 
we assessed recruitment of macrophages at day 7 post-sciatic nerve transection in WT 
and WT Cre+/WT mice. We observed no difference in the density of macrophages in the 
distal nerve segment, which suggests that Cre recombinase did not impact the recruitment 




macrophage-specific deletion of BACE1 does not play a role in enhancing recruitment of 
























Fig. 6. Macrophage-specific deletion of BACE1 does not alter recruitment of macrophages 
to the distal nerve segment post-sciatic nerve transection. 
Nerve sections, 20 µm thick, stained for CD68, a marker for macrophages 
(A,B,D,E,G,H). Macrophages recruited to the distal nerve segments of Bace1fl/fl;Lyz2 Cre 
+/WT mice (B,E,H) and Lyz2 Cre +/WT control mice (A,D,G) at 3 (A,B), 5 (D,E), and 7 
(G,H) days post-sciatic nerve transection. Quantification of macrophage density in the 
distal nerve segment post-sciatic nerve transection (C,F,I). There were no significant 
differences between genotypes at 3 days (C), p = 0.2557, 5 days (F), p = 0.8511, and 7 
days (I), p = 0.5371. Values are mean ± SD (C,F,I). For comparisons at 3 days (n=3) per 
genotype, at 5 days (n=5) for Bace1fl/fl;Lyz2 Cre+/WT and (n=4) for Lyz2 Cre+/WT, and at 7 
days (n=4) per genotype. Scale bar = 100µm. J.A. Fissel and M.H. Farah, Macrophage-
specific deletion of BACE1 does not enhance macrophage recruitment to the injured 
















Fig. 7. Lyz2 promoter-driven expression of Cre recombinase does not alter recruitment of 
macrophages to the distal nerve segment 7 days post-sciatic nerve transection. 
Nerve sections, 20µm thick, stained for CD68, a marker for macrophages (A,B). 
Macrophages recruited to the distal nerve segments of WT Lyz2 Cre+/WT (A) and WT (B) 
mice at 7 days post-sciatic nerve transection. Quantification of macrophage density in the 
distal nerve segment 7 days post-sciatic nerve transection (C). There was no significant 
difference between genotypes (n = 4), p = 0.5371, values are mean ± SD. Scale bar = 
100μm. J.A. Fissel and M.H. Farah, Macrophage-specific deletion of BACE1 does not 











Next, we sought to determine if reduction of BACE1 could modulate the behavior 
of infiltrating macrophages. Over the course of the nerve injury, the polarization state of 
macrophages transitions from a pro-inflammatory M1 polarization to a pro-regeneration 
M2 polarization (89, 119, 120). This transition is beneficial as M2 macrophages have 
been associated with improved peripheral nerve regeneration (121–123). With this in 
mind, we assessed whether cKO mice have an increased abundance of macrophages that 
have transitioned to an anti-inflammatory/pro-repair M2 phenotype. To gauge the level of 
M2 polarization, we determined what percentage of CD68+ cells in the peripheral nerve 
were also positive for CD206, a marker of M2 polarization. There was no difference in 
the percentage of macrophages that were CD206+ between cKO mice and Cre expressing 















Fig. 8. Macrophage-specific deletion of BACE1 does not alter the polarization state of 
macrophages in the distal nerve segment 5 days post-sciatic nerve transection. 
Merged images of 20µm thick nerve sections stained for a marker for macrophages 
(CD68, green) and a marker for M2 macrophage polarization (CD206, red) (A,B). 
Double positive cells appear as yellow. Populations of CD68+ macrophages that are 
positive for CD206 in the distal nerve segments of Bace1fl/fl;Lyz2 Cre+/WT mice (B) and 
Lyz2 Cre+/WT control mice at 5 days post-sciatic nerve transection (A). Quantification of 
the percentage of CD68+ macrophages that are also CD206+ 5 days post-sciatic nerve 
transection (C). There was no significant difference between genotypes (n = 3), p = 
0.3196, values are mean ± SD. Scale bar = 100μm. J.A. Fissel and M.H. Farah, 
Macrophage-specific deletion of BACE1 does not enhance macrophage recruitment to 




After observing no differences in the recruitment and polarization of macrophages in 




macrophages harvested from these mice. In previous work we have observed enhanced 
debris clearance in global BACE1 KO mice as demonstrated by increased phagocytosis 
of antibody opsonized polystyrene beads and by the observation of reduced axonal debris 
7 days post-axotomy (1). To assess if BACE1 cKO mice have the same enhanced 
phagocytic activity of global BACE1 KO mice, we used an opsonized polystyrene bead 
phagocytosis assay similar to a previous study (1). Using this assay we did not see any 
difference between the number of beads phagocytosed by cKO mice and WT Cre 













Fig. 9. Phagocytosis of opsonized beads remains unaffected in peritoneal macrophages with 




Bright field images of cultured Lyz2 Cre+/WT control (A) and Bace1fl/fl;Lyz2 Cre+/WT (B) 
peritoneal macrophages incubated with mouse gamma globulin opsonized, 3µm diameter 
polystyrene beads. Quantification of the number of beads phagocytosed per macrophage 
harvested from Bace1fl/fl;Lyz2 Cre+/WT mice and Lyz2 Cre+/WT control mice after 5 min 
incubation with opsonized beads (C). N = 3 independent experiments with 3 mice per 
genotype, p > .1 for all pairs. Values are mean ± SD. Scale bar = 100μm. J.A. Fissel and 
M.H. Farah, Macrophage-specific deletion of BACE1 does not enhance macrophage 
















Summary of chapter 2 
 In this chapter, we determined that there was no difference in macrophage 
recruitment to the distal nerve segments in mice at 3, 5, and 7 days post-transection 
between the macrophage-specific BACE1 cKO mice and Cre expressing controls in the 
injured peripheral nerve. Further, there was no difference in the polarization state of 





















Chapter 3: Conclusions 
Macrophage-specific deletion of BACE1 does not enhance macrophage 
recruitment to the injured peripheral nerve 
The following was published in J.A. Fissel and M.H. Farah, Macrophage-specific 
deletion of BACE1 does not enhance macrophage recruitment to the injured peripheral 
nerve. J Neuroimmunol 349, 577423 (2020). 
 
A previous bone marrow transplantation experiment provided some evidence that 
the immunomodulatory phenotype of macrophages in global BACE1 KO mice may be 
driven by BACE1 expressed by macrophages (65); however, it did not directly address 
the level of recruitment of macrophages nor whether other nerve resident cells could be 
contributing to macrophage recruitment. Additionally, there could also be a 
developmental effect of BACE1 expression on the phenotype of macrophages. Many of 
the phenotypes observed in global BACE1 KO mice (63, 64) are reduced or eliminated 
when BACE1 deletion is induced in adult mice (125). This could explain why we did not 
observe an increase in recruitment despite deletion of BACE1 in macrophages.  
 
Although we observed no differences in macrophage recruitment to the injured 
distal nerve segment in a cKO model, these data provide insight into the relative 
contribution of BACE1 expression by macrophages towards the enhanced macrophage 
recruitment seen in global BACE1 KO mice. This study investigated the role of 




are known to play a large role in the peripheral nerve microenvironment and express high 
levels of BACE1 (64, 116, 126). This suggests that they could be driving the enhanced 
macrophage recruitment and debris clearance phenotype. To date, a robust array of 
cytokines produced in the distal nerve segment have been implicated in recruitment of 
macrophages to the injured peripheral nerve (21–24, 29–31). Perhaps BACE1 expression 
by Schwann cells in the injured nerve microenvironment plays a role in the production of 
these cytokines, and thus recruitment and activity of macrophages.  
 
This study also highlights the need for further exploration into the alternative 
hypothesis that the enhanced recruitment and debris clearance by macrophages in global 
BACE1 KO mice may be driven by hypomyelination, rather than enhanced mobilization 
and activation of macrophages. While there is evidence of enhanced myelin and axonal 
debris clearance in global BACE1 KO mice, this effect being driven by hypomyelination 
cannot be ruled out. The observed increased debris clearance could very well be the result 
of reduced myelin debris at baseline. Neuregulin-1 (NRG1) KO mice display similar 
levels of hypomyelination as BACE1 KO mice. NRG1 is a BACE1 substrate and 
signaling molecule critical for myelination. The absence of NRG1 during development 
results in hypomyelination; however, mice with an inducible axon-specific deletion of 
NRG1 show no myelination abnormalities when NRG1 is ablated post-development 
(127, 128). Following peripheral nerve injury, inducible NRG1 KO mice show attenuated 
remyelination of axons but no difference in axonal regeneration, myelin debris clearance, 





In summary, this study suggests that expression of BACE1 by adult macrophages 
may not be essential in mediating the increased macrophage recruitment to the injured 
distal nerve segment observed in global BACE1 KO mice. These data is limited to the 
role of BACE1 expression by macrophages in the context of peripheral nerve injury, but 
not broader immunomodulatory states. Further investigation into the expression of 
BACE1 by other cell types in the regenerating peripheral nerve microenvironment may 
answer questions posed by this study. Alternatively, future studies could be directed at 
testing the hypothesis that this observed phenotype is the result of the hypomyelination 
observed in these mice, rather than immunomodulatory effects on macrophages driven by 









Fig. 10. Summary of results of macrophage-specific deletion of BACE1 in injured nerves of 
adult mice and in vitro phagocytosis assay. 
A representation of the results of chapter 2. Mouse genotypes are listed (left) along with 
results of in vivo (center) and in vitro (right) data. BACE1 genotype by cell type is 
indicated by color, orange cells have WT BACE1, purple cells have deletion of BACE1.   
There is no difference in macrophage recruitment to the distal nerve segment between 
Bace1fl/fl;Lyz2 Cre+/WT mice and Lyz2 Cre+/WT control mice following nerve injury. 
Bottom row summarizes previously published enhanced recruitment phenotype in global 
BACE1 and enhanced in vitro phagocytosis of global BACE1 KO macrophages. J.A. 
Fissel and M.H. Farah, Macrophage-specific deletion of BACE1 does not enhance 






Results of macrophage-specific deletion of BACE1 and the implications 
for potential immunomodulatory mechanisms of BACE1 substrates 
Mice with macrophage-specific deletion of BACE1 do not share the same levels 
of enhanced macrophage recruitment as global BACE1 KO mice (124). This suggests 
that the enhanced recruitment phenotype is mediated by other cell type(s) in the injured 
nerve microenvironment. As discussed in chapter 1 there are several BACE1 substrates 
that are known to have immunomodulatory effects, and some have been documented in 
the context of peripheral nerve injury. In light of the results of chapter 2 further 
discussion of how each of these substrates may or may not play a role is warranted.  
 IL-1 signaling can impact macrophages in a variety of ways. However, given the 
results of chapter 2, reduced BACE1 cleavage of IL-1R2 by macrophages is unlikely to 
play a role in enhancing macrophage recruitment to the injured nerve. Loss of BACE1 
cleavage IL-1R2 could still be impacting macrophage recruitment through neurons and 
Schwann cells during the initial damage associated inflammatory signaling following 
nerve injury(22, 23, 89). Reduced BACE1 activity in these cells could reduce the amount 
of shed IL-1R2 (58, 84, 85) released into the extracellular milieu that, in the presence of 
BACE1 activity, could bind Schwann cell derived IL-1 in this space and prevent IL-1 
signaling, thus loss of BACE1 could increase inflammatory signaling. While it is 
understood that BACE1 activity likely plays a role in the extracellular shedding of IL-
1R2, it is not well understood if it plays a role in the generation of intracellular IL-1R2. If 
BACE1 can alter levels of intracellular IL-1R2 then this would provide another potential 
avenue for reduced BACE1 activity to play a role in DAMP signaling in neurons and 




 The results of chapter 2 may also change how Notch signaling could be playing a 
role in global BACE1 mice. BACE1 is known to be expressed by neurons and Schwann 
cells and there is evidence that it plays a role in the regulation of Notch signaling through 
cleavage of Jag1(94). In the absence of BACE1 cleavage there would be an excess of 
Jag1 on the cell surface of neurons and Schwann cells that may result in increased 
signaling with macrophage derived Notch (98, 99). There is evidence that this results in 
an increase of inflammatory markers in macrophages . This increased inflammation could 
result in the enhanced recruitment and debris clearance seen in global BACE1 KO mice.  
 BACE1 activity has been shown to enhance binding of macrophages to adhesion 
molecules associated with endothelial cells in vitro and could potentially benefit 
trafficking and recruitment through cleavage of ST6gal-1 (25, 106). Under inflammatory 
conditions macrophages upregulate BACE1 cleavage of ST6gal-1 and increase the 
binding affinity for VCAM-1 in vitro (25). There is also evidence that BACE1 activity 
decreases endothelial cell-cell binding affinity through cleavage of ST6gal-1 (25). Given 
that the effects of BACE1 activity seem to be beneficial in the context of ST6gal-1 
perhaps the role of this substrate would be buoyed by further studies into the possibility 
that the enhanced recruitment and debris clearance in BACE1 global KO mice is the 
result of hypomyelination. 
 Finally, PSGL-1’s possibilities for playing a role in the immunomodulatory 
phenotype of global BACE1 KO mice become increasingly unlikely. PSGL-1 is 
expressed by macrophages and binds p-selectin on endothelial cells to initiate the 
adhesion cascade resulting in rolling, tethering, and arrest during trafficking from the 




PSGL-1 on the surface of macrophages that would be able to bind p-selectin and increase 
trafficking from the bloodstream and recruitment to the injured nerve (108). While any 
role for PSGL-1 cannot be ruled out, it is unlikely to be a primary driver of this 
phenotype.  
 While none of these substrates can be ruled out by the results of chapter 2, it does 
provide some insight into which mechanisms may be more important to the BACE1 KO 
macrophage phenotype. This phenotype is likely a combination of many different 




 This thesis demonstrates that macrophage-specific deletion of BACE1 has no 
effect on the recruitment of macrophages to the injured peripheral nerve of adult mice 
following injury. Further research into the potential effects of cell type specific deletion 
of other constituent cells of the injured nerve microenvironment is warranted. 
Alternatively, further study into the hypothesis that this enhanced recruitment and activity 
of macrophages may be due to hypomyelination in global BACE1 KO mice is also 
merited. Further assessment of potential roles of BACE1 substrates IL-1R2, Jag-1, 
ST6gal-1, and PSGL-1 in the injured nerve would also provide insight into potential 
mechanisms of this phenotype in global BACE1 KO mice. Further, interrogating each 
cell type in the peripheral nerve micro environment with cell type specific deletion of 
BACE1 could also help guide future inquiries into which BACE1 substrates are likely to 




Chapter 4: Methods 
Animals  
Conditional knockout mice were on a C57BL/6 background and bred by crossing 
floxed Bace1 mice,  C57BL/6-Bace1tm1.1mrl  (Taconic Biosciences, Rensselaer, NY, USA) 
(129), with mice expressing Cre recombinase under control of Lyz2 promoter/enhancer 
elements, B6.129P2-Lyz2tm1(cre)Ifo  (The Jackson Laboratory, Bar Harbor, ME, USA). 
Macrophage-specific cKO mice were homozygous for the floxed Bace1 allele and 
heterozygous for Cre recombinase (Bace1fl/fl;Lyz2 Cre+/WT). Control mice were C57BL/6 
wild type (WT) mice that were heterozygous for Cre recombinase (Lyz2 Cre+/WT). A total 
of 79 mice between 10-16 weeks old were used in this study. Roughly equal amounts of 
male and female mice were used in this study as there was no significant difference 
between male and female in BACE1 expression, macrophage recruitment, or macrophage 
activity. The animal surgeries and experimental protocols were approved by the Animal 
Care and Use Committee of the Johns Hopkins University School of Medicine. 
 
Peritoneal macrophage harvest and culture 
Mice were killed by CO2 asphyxiation, and a small incision in the skin was made 
to expose the peritoneum. 5 mL of cold Gibco RPMI 1640 media (Thermo Fisher 
Scientific, Waltham, MA, USA) with 10% Gibco fetal bovine serum (FBS) (Thermo 
Fisher Scientific, Waltham, MA, USA) and 1% penicillin-streptomycin was injected into 
the peritoneal cavity and gently massaged for 15 seconds. RPMI was aspirated with a 




media, a small incision was then made in the peritoneal membrane and media was 
aspirated by transfer pipet (130). Cells were then spun at 250 X g for 10 min, 
resuspended and counted. Approximately 60,000 cells/well were seeded onto glass 
coverslips in 24 well plates for phagocytosis assays, and 2x106 cells/well were seeded 
into 6 well plates for expression analysis. These cells were then incubated at 37°C and 
5% CO2 for 1 h to allow peritoneal macrophages to adhere to the cell culture dish. 
Following incubation, wells were washed to remove contaminating cells, leaving behind 
adhered macrophages. Cells were then either immediately used for expression analysis or 
incubated 24 h prior to phagocytosis assays. Mice used for macrophage BACE1 
expression analysis in an inflammatory context were treated by injection of 1 mL of 3% 
Brewer thioglycollate medium (Millipore Sigma, Burlington, MA, USA) into the 
peritoneal cavity 4 days prior to harvest. 
 
RT-PCR 
Total RNA was extracted from peritoneal macrophages from each mouse with 
Quick-RNA Miniprep Kit (Zymo Research, Irvine, CA, USA) then cleaned and 
concentrated (RNA Clean & Concentrator-25, Zymo Research, Irvine, CA, USA). 
Quality and concentration of RNA was determined by Nanodrop. One microgram of 
RNA was added to each reaction, and a cDNA library was reverse transcribed for each of 
the samples using Invitrogen SuperScript III first-strand synthesis system kit (Thermo 
Fisher Scientific, Waltham, MA, USA). The cDNA libraries were then combined with 
Quantitect SYBR Green PCR Kit (Qiagen, Germantown, MD, USA). For each 




amplify BACE1 and B2M transcripts in the peritoneal macrophages. B2M was selected 
as a reference gene based on reports of improved stability in macrophages in an 
inflammatory context (131).  BACE1 primers were selected to have one primer binding 
site in exon 2, which is deleted in the presence of Cre recombinase, and another primer 
binding site in exon 3. The following primers were used: BACE1 primers, 5’-
CCTTTCCTGCATCGCTACTAC-3’ (forward); 5’-GGGCACATACACACCCTTT-3’ 
(reverse) and B2M primers, 5’-GGGTGGAACTGTGTTACGTAG-3’ (forward); 5’-
TGGTCTTTCTGGTGCTTGTC-3’ (reverse). Each sample was run in triplicate and  
analyzed by 7900HT Fast Real-Time PCR System (Applied Biosystems, Waltham, MA, 
USA). All values were normalized to B2M mRNA and reported as fold change from WT 
levels.  
 
Sciatic nerve transection 
Mice were anesthetized with 2% isoflurane (Baxter, Deerfield, IL, USA), and fur 
covering the skin on the left thigh was shaved with an electric hair trimmer. Mice were 
continuously supplied with isoflurane, and surgeries were performed under sterile 
conditions. A small incision was made in the skin along the thigh to expose underlying 
muscle and connective tissue. With surgical microscope, a small incision was made in the 
connective tissue at midthigh, and a surgical retractor was used to expose the nerve. 
Small surgical scissors were then used to transect the nerve, and the distal end was tucked 
away from the proximal end to prevent regeneration of the axons. The wound was then 
sutured closed. Distal nerve segments and uncut contralateral controls were harvested at 






Mice were deeply anesthetized with 10% chloral hydrate (Millipore Sigma, 
Burlington, MA), briefly exsanguinated with Gibco 1x phosphate-buffered saline (PBS) 
solution (Thermo Fisher Scientific, Waltham, MA, USA), then perfused with 2% 
paraformaldehyde (PFA) in 1x PBS solution for immunofluorescence and 2% PFA/2% 
glutaraldehyde in 1x PBS solution for light microscopy.  
 
Myelinated axon quantification 
Following perfusion, nerves were dissected out, post-fixed in 2% PFA/2% 
glutaraldehyde in 1x PBS solution overnight at room temperature (RT), and embedded in 
plastic. Nerves were then cross-sectioned at 1 µm thickness and stained for toluidine 
blue. Images of the nerve sections were taken at 100x magnification. Myelinated axon 
density was determined by counting the number of myelinated axons in a measured area 
(0.01mm2) using Zeiss Zen image analysis software. For the quantification of myelin 
thickness and g-ratio, 200 myelinated axons were analyzed for each mouse, at random, 
from 3 fields of view from each of 3 different cross sections. For each myelinated axon, 
the axon diameter and the nerve fiber diameter were determined by ImageJ 1.52a. Myelin 
thickness was calculated as (fiber diameter – axon diameter)/2, and g-ratio was calculated 






Following perfusion, nerves were dissected out, and 3 mm of nerve tissue at the 
cut end was discarded before further processing of distal nerve segment. The remaining 
nerve was post-fixed in 2% PFA solution overnight at RT. Nerves were then washed with 
1x PBS and cryoprotected in 30% sucrose in 1x PBS overnight at 4°C. Nerve tissue was 
then immersed in Tissue-Tek O.C.T. Compound, flash frozen, and sectioned 
longitudinally at 20 µm thickness by cryostat (Microm HM 505E). Sectioned nerves were 
washed in 1x PBS for 10 min at 37°C, and washed again 2 times for 10 min at RT in 1x 
PBS with .3% Triton X-100 (PBST) to remove O.C.T. compound and permeabilize the 
tissue. Sections were then blocked with PBST with 5% normal goat serum (NGS) for 1h 
at RT. Next, sections were incubated with PBST 1% NGS with primary antibody 
overnight at 4°C. Anti-CD68 (1:1000 BioLegend) antibodies were used as a marker for 
macrophages and anti-CD206 (1:1000 Santa Cruz) was used as a marker of M2 
polarization. Nerves were then washed with 1x PBST 2 times for 15 min before 
incubation with appropriate secondary antibodies (Alexa Fluor 488 and Alexa Fluor 546 
(Invitrogen)) diluted at 1:1000 in PBST with 1% NGS for 1h at RT. Slides were again 
washed twice for 15 min in PBST before mounted with Life Technologies Prolong Gold 
Anti-fade with DAPI (Thermo Fisher Scientific, Waltham, MA, USA) and coverslipped. 
Sciatic nerves were then imaged using a Axio Imager Fluorescence Microscope (Zeiss, 
Oberkochen, Germany). Images used in macrophage recruitment analysis were acquired 
in 3D z-stacks in 2µm intervals at 20x magnification in 3 fields of view. 
 




Macrophages were quantified by counting CD68+ cells using Zeiss Zen image 
analysis software. Individual cells were determined by DAPI staining of cell nuclei and 
analyzing multiple focal planes. The area of each nerve was then traced and quantified 
for volume calculations (62). Density of macrophages was calculated using the total 
number of macrophages and the volume of the image. M2 macrophage polarization was 
determined by counting all CD68+ cells and CD206+ cells in the same manner and 
reported as a percentage of CD68+ cells that were also positive for CD206. 
 
Phagocytosis assay 
To prepare opsonized bead solution, 3 µm diameter polystyrene beads (Millipore 
Sigma, Burlington, MA, USA) were opsonized with mouse IgG (Thermo Fisher 
Scientific, Waltham, MA, USA) during 1h incubation at 37°C. Beads were then diluted to 
a 10:1 ratio with peritoneal macrophages. Following 24h incubation post cell harvest, 
peritoneal macrophages (harvested as stated in section 2.2) were centrifuged with the 
opsonized bead solution for 1 min at 250 X g and incubated at 37°C for an additional 5 
min. Following incubation, uningested beads were washed away with 1x PBS and the 
remaining macrophages were fixed with 3% PFA solution. Coverslips were then mounted 
and imaged with at 40x magnification in z-stacks in in 2 µm intervals at 3 fields of view. 
Total cells and beads phagocytosed by each cell were counted. This was performed in 3 






Each mouse was randomly assigned a number and neither the thioglycollate 
treatment status nor genotype was known throughout data collection and analysis to 
ensure blinded analysis of the data. All statistical analysis was performed using a 
Student’s t-test. All data analysis was performed using GraphPad Prism 8, and any value 
of p < 0.05 was scored as statistically significant. All graphed data was generated using 
GraphPad Prism 8 and presented as mean ± standard deviation. 
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